xIPOmeter
Tessera Therapeutics
Tessera Therapeutics is a biotechnology company dedicated to developing next-generation genetic tools that go beyond editing to actually write new DNA sequences. By harnessing their proprietary “Gene Writing” platform, they aim to precisely alter the genetic code at its source, enabling the creation of new therapeutic possibilities for a wide range of diseases. Their approach holds the potential to correct underlying genetic errors, expand the horizons of personalized medicine, and fundamentally reshape how we address genetic conditions.
NewsHeat chart
- Week
- Month
- Year
- Media news
- Corp news
The data in the chart above is based on data derived from our proprietary XP calculation model and may be changed, adjusted and updated without prior notice
Company Valuation
- Valuation
- Share Price
- Cumulative Funding
The data in the tables and charts is based on data from public sources and although we make every effort to compile the data, it may not coincide with the actual data of the issuer.
*** - To view the data, please log into your account or create a new one.
Company valuation calculator
To calculate, specify one of the parameters
News related to Tessera Therapeutics1
Tessera TherapeuticsTessera Therapeutics Receives Investment From Bill & Melinda Gates Foundation
The funding included an initial investment, with potential total investment of up to $50M. ...
https://www.finsmes.com/2024/12/tessera-therapeutics-receives-investment-from-bill-melinda-gates-foundation.html
Investors3
Bill & Melinda Gates Foundation
SoftBank Vision Fund
T. Rowe Price